Final agreement reached in Connecticut for new Jackson Laboratory research institute
|Date: January 5, 2012||
Bar Harbor, Maine – An agreement for The Jackson Laboratory to create a new institute for genomics-based personalized medicine in Connecticut has gained final approval, Connecticut Gov. Dannel P. Malloy announced today.
The announcement follows the Oct. 26 approval by the Connecticut General Assembly of $291 million in bond funding, and subsequent negotiations among the Laboratory, Connecticut Innovations, the University of Connecticut and the UConn Health Center.
“We’re delighted that we could reach an agreement so quickly for JAX Genomic Medicine,” said Jackson President and CEO Edison Liu, M.D. “We’ve been working hard over these weeks of negotiations, and the process has helped us build strong working relationships with our new colleagues.”
Liu added, “Our grand vision is for personalized, individual and precise medical care…. The goal of The Jackson Laboratory for Genomic Medicine is to use the world's most cutting-edge science to make this vision a reality, and in the process contribute to Connecticut’s bioscience economy."
Gov. Malloy also hailed the agreement’s completion. "For the project's impact to begin as soon as possible - to get people working and to start the flow of bioscience investments - it was important to get it moving forward quickly," Malloy said. "I want to commend everyone in on the negotiations, from all the state agencies involved and the Jackson representatives, for putting together an agreement that provides a good return to Connecticut taxpayers, serves the interests of the state, and allows The Jackson Laboratory to grow and expand. And it was all accomplished in a timeframe that will have The Jackson Laboratory contributing to Connecticut's economy in 2012, and even hiring this quarter."
JAX Genomic Medicine will be built on a 17-acre site on the UConn Health Center campus in Farmington. Initial operations will begin this year in leased space while a 173,000-square-foot permanent facility is designed and built. Construction will begin in 2013, and the new facility will open in 2014. It will house 300 biomedical researchers, technicians and support staff in state-of-the-art computing facilities and laboratories.
JAX Genomic Medicine will draw upon Jackson’s eight decades of research and the medical expertise of Connecticut’s universities and hospitals, including UConn Health Center and Yale University School of Medicine. The research institute will unite doctors, patients, scientists and industry to find new ways to tailor disease diagnosis, prevention and treatment to each person’s unique genetic makeup, or genome.
JAX Genomic Medicine is an expansion, not a relocation, of The Jackson Laboratory. JAX will continue to grow its basic research campus in Bar Harbor, Maine, while the new facility in Connecticut focuses on medical applications of genomics and personalized medicine with academic and clinical research partners in Connecticut and around the world.
The Jackson Laboratory is an independent, nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center based in Bar Harbor, Maine, with a facility in Sacramento, Calif., and a total staff of about 1,400. Its mission is to discover the genetic basis for preventing, treating and curing human disease, and to enable research and education for the global biomedical community.
Joyce Peterson, 207-288-6058, The Jackson Laboratory
Media Relations, Communications Office
The Jackson Laboratory
600 Main Street
Bar Harbor, Maine 04609-1500
Phone: 207-288-6058 (journalists only)
Main Jackson Laboratory phone: 207-288-6000